Dr. Filosso on Future of Treating Patients With Lung NETs

Video

Pier Luigi Filosso, MD, associate professor of Thoracic Surgery, University of Torino, Italy, discusses future approaches to treating patients with neuroendocrine tumors of lung origin.

Pier Luigi Filosso, MD, associate professor of Thoracic Surgery, University of Torino, Italy, discusses future approaches to treating patients with neuroendocrine tumors (NETs) of lung origin.

The backbone treatment for these patients will be surgery, Filosso explains. However, there needs to be new targeted therapies for patients with aggressive disease in terms of lymph node metastasis.

It is known that patients with low- and intermediate-risk tumors may develop recurrence or distant metastasis. Therefore, a strict clinical treatment plan needs to be developed for this population, Filosso adds.

Related Videos
Eduardo Sotomayor, MD
James Knight, MD
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine
Matthew Galsky, MD, professor of medicine, Hematology and Medical Oncology, director, Genitourinary Medical Oncology, codirector, Center of Excellence for Bladder Cancer, associate director, Translational Research, The Tisch Cancer Institute of Mount Sinai
Daneng Li, MD
Andre Goy, MD
Efrat Dotan, MD
Rachid Baz, MD, section head, Myeloma, Department of Malignant Hematology, Moffitt Cancer Center; co-director, Pentecost Family Myeloma Research Center
Marijo Bilusic, MD, PhD, GU site disease group lead, GU SDD medical oncology lead, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School